Misti Brown
Family · Moulton, ALNPI 1841689213
Payments from drug & device makers
Across 128 payments — averaging $16.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$509
- Lilly USA, LLC$192
- Indivior Inc.$177
- Corcept Therapeutics$158
- Bayer$138
- Amgen$94
- plus $816 from 21 others
What the payments were for
- Food & beverage$2,083100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 50 | $509 |
| Lilly USA, LLC | 10 | $192 |
| Indivior Inc. | 6 | $177 |
| Corcept Therapeutics | 7 | $158 |
| Bayer | 7 | $138 |
| Amgen | 5 | $94 |
| Novo Nordisk | 5 | $89 |
| AstraZeneca | 5 | $86 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $79 |
| Pfizer | 4 | $70 |
| GSK | 3 | $54 |
| Alkermes, Inc. | 2 | $50 |
| Abbott | 2 | $42 |
| Astellas Pharma US Inc | 2 | $39 |
| Phathom Pharmaceuticals, Inc. | 2 | $36 |
| Otsuka America Pharmaceutical, Inc. | 2 | $34 |
| Vanda Pharmaceuticals Inc. | 1 | $33 |
| Axsome Therapeutics, Inc. | 2 | $31 |
| Novartis | 1 | $24 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $23 |
| Xeris Pharmaceuticals, Inc. | 1 | $23 |
| Mylan Specialty L.p. | 1 | $21 |
| Exact Sciences | 1 | $21 |
| Lundbeck LLC | 1 | $20 |
| Boehringer Ingelheim | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| Eisai Inc. | 1 | $12 |
How this compares
$2,083 in reported general payments places this provider in the 75th percentile of 3,415 family providers in Alabama.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 77 | $113,333 |
| JardianceEmpagliflozin | 79 | $85,888 |
| TrulicityDulaglutide | 71 | $69,974 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 37 | $31,059 |
| FarxigaDapagliflozin Propanediol | 38 | $25,183 |
| JanuviaSitagliptin Phosphate | 15 | $23,606 |
| Invega SustennaPaliperidone Palmitate | 13 | $21,994 |
| LinzessLinaclotide | 22 | $19,362 |
| EliquisApixaban | 16 | $17,381 |
| VascepaIcosapent Ethyl | 31 | $14,416 |
| Repatha SureclickEvolocumab | 15 | $12,152 |
| MyrbetriqMirabegron | 14 | $6,429 |
| Xigduo XrDapaglifloz Propaned/Metformin | 11 | $6,004 |
| Dexlansoprazole DrDexlansoprazole | 19 | $5,576 |
| Tresiba Flextouch U-100Insulin Degludec | 14 | $5,561 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $192 | $183,307148 claims |
| Boehringer IngelheimJardiance | $16 | $85,88879 claims |
| GSKTrelegy Ellipta | $54 | $31,05937 claims |
| AstraZenecaFarxiga, Symbicort | $86 | $30,09654 claims |
| AbbVieLinzess | $509 | $19,36222 claims |
| PfizerEliquis | $70 | $17,38116 claims |
| Astellas Pharma US IncMyrbetriq | $39 | $6,42914 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,415 family providers in Alabama.
Other family in Moulton
- Justin WilsonCullman$1.1M
- Leigh Ann ChildressHuntsville$240K
- Molly ReevesAuburn$158K
- Christina CanteyHuntsville$118K
- Leigh LunaMontgomery$69K
- Christopher LovellMobile$64K
- Justin SimpsonTuscaloosa$43K
- Kellyn McMahonBirmingham$39K
- Ashley StinesTuscaloosa$29K
- Brandy YoungMontgomery$27K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.